Big endothelin in chronic heart failure:marker of disease
severity or genetic determination?

J 2004

Big endothelin in chronic heart failure:marker of disease severity or genetic determination?

ŠPINAROVÁ, Lenka, Jindřich ŠPINAR, Anna VAŠKŮ, Monika GOLDBERGOVÁ, Ondřej LUDKA et. al.

Základní údaje

Originální název

Big endothelin in chronic heart failure:marker of disease severity or genetic determination?

Název česky

Big endotelin u chronického srdečního selhání:ukazatel tíže onemocnění nebo genetická determinace?

Autoři

ŠPINAROVÁ, Lenka (203 Česká republika, garant, domácí), Jindřich ŠPINAR (203 Česká republika, domácí), Anna VAŠKŮ (203 Česká republika, domácí), Monika GOLDBERGOVÁ (203 Česká republika, domácí), Ondřej LUDKA (203 Česká republika, domácí), Jiří TOMAN (203 Česká republika), Jiří VÍTOVEC (203 Česká republika, domácí), Marie TOMANDLOVÁ (203 Česká republika, domácí) a Josef TOMANDL (203 Česká republika, domácí)

Vydání

International Journal of Cardiology, Ireland, Elsevier, 2004, 0167-5273

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.095

Kód RIV

RIV/00216224:14110/04:00012156

Organizační jednotka

Lékařská fakulta

UT WoS

000188927500011

Klíčová slova anglicky

Big endothelin; genetic; chronic heart failure; polymorphism

Štítky

Big endothelin, chronic heart failure, genetic, polymorphism

Změněno: 6. 6. 2012 08:35, doc. RNDr. Josef Tomandl, Ph.D.

Anotace

ORIG CZ

V originále

The first objective of the study was to compare the levels of big endothelin and endothelin-1 and other noninvasive parameters used for evaluation of disease severity in patients with stable chronic heart failure (CHF). Endothelin-1 and big endothelin plasma concentrations were measured in 124 chronic heart failure patients. The second objective of the study was to prove an association between endothelin-1 and big endothelin plasma levels and two frequent polymorphisms in the endothelin-1 coding gene (6p21-23) -3A/-4A and G (8002) A in patients with chronic heart failure. Thirdly, we tried to associate other noninvasive parameters of CHF, especially cardiothoracic index (CTI), NYHA classification, signs of pulmonary congestion (PC) and ejection fraction (EF) with determined genotypes of the two ET-1 polymorphic variants. There were significant differences between big endothelin levels in NYHA II versus IV (P<0.001) and NYHA III versus IV (P<0.001) and endothelin-1 in NYHA II versus IV (P<0.001) and NYHA III versus IV (P<0.001). No associations between plasma levels of endothelin-1 and big endothelin and polymorphisms G (8002) A and -3A/-4A in gene coding endothelin-1 were found. In patients with CHF with CTI above 60% the number of carriers of genotypes with ET-1 8002A (AA and AG genotypes) increases. Concerning on the -3A/-4A ET-1 polymorphism, we observed a significant difference in genotype distribution as well as in allelic frequency in the group of patients with CTI above 60% between patients without and with pulmonary congestion. The allelic frequency of 3A allele is twice elevated in the patients with pulmonary congestion (37.8 vs. 78.1%, respectively).

Česky

Big endotelin u chronického srdečního selhání: ukazatel tíže onemocnění nebo genetická determinace .

Návaznosti

NA7360, projekt VaV

Název: Genetické podklady humorální aktivace u chronického srdečního selhání

Investor: Ministerstvo zdravotnictví ČR, Genetické podklady humorální aktivace u chronického srdečního selhání

Citovat

ŠPINAROVÁ, Lenka, Jindřich ŠPINAR, Anna VAŠKŮ, Monika GOLDBERGOVÁ, Ondřej LUDKA, Jiří TOMAN, Jiří VÍTOVEC, Marie TOMANDLOVÁ a Josef TOMANDL. Big endothelin in chronic heart failure:marker of disease severity or genetic determination? International Journal of Cardiology. Ireland: Elsevier, 2004, roč. 93, č. 1, s. 63-68. ISSN 0167-5273.

@article{491942,
   author = {Špinarová, Lenka and Špinar, Jindřich and Vašků, Anna and Goldbergová, Monika and Ludka, Ondřej and Toman, Jiří and Vítovec, Jiří and Tomandlová, Marie and Tomandl, Josef},
   article_location = {Ireland},
   article_number = {1},
   keywords = {Big endothelin; genetic; chronic heart failure; polymorphism},
   language = {eng},
   issn = {0167-5273},
   journal = {International Journal of Cardiology},
   title = {Big endothelin in chronic heart failure:marker of disease severity or genetic determination?},
   volume = {93},
   year = {2004}
}

TY  - JOUR
ID  - 491942
AU  - Špinarová, Lenka - Špinar, Jindřich - Vašků, Anna - Goldbergová, Monika - Ludka, Ondřej - Toman, Jiří - Vítovec, Jiří - Tomandlová, Marie - Tomandl, Josef
PY  - 2004
TI  - Big endothelin in chronic heart failure:marker of disease severity or genetic determination?
JF  - International Journal of Cardiology
VL  - 93
IS  - 1
SP  - 63
EP  - 63
PB  - Elsevier
SN  - 01675273
KW  - Big endothelin
KW  - genetic
KW  - chronic heart failure
KW  - polymorphism
N2  - The first objective of the study was to compare the levels of big endothelin and endothelin-1 and other noninvasive parameters used for evaluation of disease severity in patients with stable chronic heart failure (CHF). Endothelin-1 and big endothelin plasma concentrations were measured in 124 chronic heart failure patients. The second objective of the study was to prove an association between endothelin-1 and big endothelin plasma levels and two frequent polymorphisms in the endothelin-1 coding gene (6p21-23) -3A/-4A and G (8002) A in patients with chronic heart failure. Thirdly, we tried to associate other noninvasive parameters of CHF, especially cardiothoracic index (CTI), NYHA classification, signs of pulmonary congestion (PC) and ejection fraction (EF) with determined genotypes of the two ET-1 polymorphic variants. There were significant differences between big endothelin levels in NYHA II versus IV (P<0.001) and NYHA III versus IV (P<0.001) and endothelin-1 in NYHA II versus IV (P<0.001) and NYHA III versus IV (P<0.001). No associations between plasma levels of endothelin-1 and big endothelin and polymorphisms G (8002) A and -3A/-4A in gene coding endothelin-1 were found. In patients with CHF with CTI above 60% the number of carriers of genotypes with ET-1 8002A (AA and AG genotypes) increases. Concerning on the -3A/-4A ET-1 polymorphism, we observed a significant difference in genotype distribution as well as in allelic frequency in the group of patients with CTI above 60% between patients without and with pulmonary congestion. The allelic frequency of 3A allele is twice elevated in the patients with pulmonary congestion (37.8 vs. 78.1%, respectively).
ER  -

ŠPINAROVÁ, Lenka, Jindřich ŠPINAR, Anna VAŠKŮ, Monika GOLDBERGOVÁ, Ondřej LUDKA, Jiří TOMAN, Jiří VÍTOVEC, Marie TOMANDLOVÁ a Josef TOMANDL. Big endothelin in chronic heart failure:marker of disease severity or genetic determination? \textit{International Journal of Cardiology}. Ireland: Elsevier, 2004, roč.~93, č.~1, s.~63-68. ISSN~0167-5273.

Podrobný výpis o publikaci